These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21175567)

  • 1. Anti-angiogenic effects of two cystine-knot miniproteins from tomato fruit.
    Cavallini C; Trettene M; Degan M; Delva P; Molesini B; Minuz P; Pandolfini T
    Br J Pharmacol; 2011 Mar; 162(6):1261-73. PubMed ID: 21175567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cystine-knot miniprotein from tomato fruit inhibits endothelial cell migration and angiogenesis by affecting vascular endothelial growth factor receptor (VEGFR) activation and nitric oxide production.
    Treggiari D; Zoccatelli G; Molesini B; Degan M; Rotino GL; Sala T; Cavallini C; MacRae CA; Minuz P; Pandolfini T
    Mol Nutr Food Res; 2015 Nov; 59(11):2255-66. PubMed ID: 26255647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tomato cystine-knot miniproteins possessing anti-angiogenic activity exhibit in vitro gastrointestinal stability, intestinal absorption and resistance to food industrial processing.
    Treggiari D; Zoccatelli G; Chignola R; Molesini B; Minuz P; Pandolfini T
    Food Chem; 2017 Apr; 221():1346-1353. PubMed ID: 27979099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plant cystine-knot peptides: pharmacological perspectives.
    Molesini B; Treggiari D; Dalbeni A; Minuz P; Pandolfini T
    Br J Clin Pharmacol; 2017 Jan; 83(1):63-70. PubMed ID: 26987851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and MALDI-TOF Mass Spectrometric Characterization of a Novel Native and Recombinant Cystine Knot Miniprotein from Solanum tuberosum subsp. andigenum cv. Churqueña.
    Cotabarren J; Tellechea ME; Tanco SM; Lorenzo J; Garcia-Pardo J; Avilés FX; Obregón WD
    Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combinatorial optimization of cystine-knot peptides towards high-affinity inhibitors of human matriptase-1.
    Glotzbach B; Reinwarth M; Weber N; Fabritz S; Tomaszowski M; Fittler H; Christmann A; Avrutina O; Kolmar H
    PLoS One; 2013; 8(10):e76956. PubMed ID: 24146945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-angiogenic and vascular disrupting effects of C9, a new microtubule-depolymerizing agent.
    Ren X; Dai M; Lin LP; Li PK; Ding J
    Br J Pharmacol; 2009 Apr; 156(8):1228-38. PubMed ID: 19302593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NSK-01105, a novel sorafenib derivative, inhibits human prostate tumor growth via suppression of VEGFR2/EGFR-mediated angiogenesis.
    Yu P; Ye L; Wang H; Du G; Zhang J; Zuo Y; Zhang J; Tian J
    PLoS One; 2014; 9(12):e115041. PubMed ID: 25551444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic Cystine-Knot Miniproteins - Valuable Scaffolds for Polypeptide Engineering.
    Avrutina O
    Adv Exp Med Biol; 2016; 917():121-44. PubMed ID: 27236555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589.
    Qian DZ; Kato Y; Shabbeer S; Wei Y; Verheul HM; Salumbides B; Sanni T; Atadja P; Pili R
    Clin Cancer Res; 2006 Jan; 12(2):634-42. PubMed ID: 16428510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-angiogenic properties of a sulindac analogue.
    Pyriochou A; Tsigkos S; Vassilakopoulos T; Cottin T; Zhou Z; Gourzoulidou E; Roussos C; Waldmann H; Giannis A; Papapetropoulos A
    Br J Pharmacol; 2007 Dec; 152(8):1207-14. PubMed ID: 17965739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isogambogenic acid inhibits tumour angiogenesis by suppressing Rho GTPases and vascular endothelial growth factor receptor 2 signalling pathway.
    Fan Y; Peng A; He S; Shao X; Nie C; Chen L
    J Chemother; 2013 Oct; 25(5):298-308. PubMed ID: 24070138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-angiogenic effect of quercetin and its 8-methyl pentamethyl ether derivative in human microvascular endothelial cells.
    Lupo G; Cambria MT; Olivieri M; Rocco C; Caporarello N; Longo A; Zanghì G; Salmeri M; Foti MC; Anfuso CD
    J Cell Mol Med; 2019 Oct; 23(10):6565-6577. PubMed ID: 31369203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-angiogenic activity of the flavonoid precursor 4-hydroxychalcone.
    Varinska L; van Wijhe M; Belleri M; Mitola S; Perjesi P; Presta M; Koolwijk P; Ivanova L; Mojzis J
    Eur J Pharmacol; 2012 Sep; 691(1-3):125-33. PubMed ID: 22721615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclopeptide RA-V inhibits angiogenesis by down-regulating ERK1/2 phosphorylation in HUVEC and HMEC-1 endothelial cells.
    Yue GG; Fan JT; Lee JK; Zeng GZ; Ho TW; Fung KP; Leung PC; Tan NH; Lau CB
    Br J Pharmacol; 2011 Dec; 164(7):1883-98. PubMed ID: 21518338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PE, a new sulfated saponin from sea cucumber, exhibits anti-angiogenic and anti-tumor activities in vitro and in vivo.
    Tian F; Zhang X; Tong Y; Yi Y; Zhang S; Li L; Sun P; Lin L; Ding J
    Cancer Biol Ther; 2005 Aug; 4(8):874-82. PubMed ID: 16082187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic concentrations of digitoxin inhibit endothelial focal adhesion kinase and angiogenesis induced by different growth factors.
    Trenti A; Zulato E; Pasqualini L; Indraccolo S; Bolego C; Trevisi L
    Br J Pharmacol; 2017 Sep; 174(18):3094-3106. PubMed ID: 28688145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allotides: Proline-Rich Cystine Knot α-Amylase Inhibitors from Allamanda cathartica.
    Nguyen PQ; Luu TT; Bai Y; Nguyen GK; Pervushin K; Tam JP
    J Nat Prod; 2015 Apr; 78(4):695-704. PubMed ID: 25832441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morelloflavone, a biflavonoid, inhibits tumor angiogenesis by targeting rho GTPases and extracellular signal-regulated kinase signaling pathways.
    Pang X; Yi T; Yi Z; Cho SG; Qu W; Pinkaew D; Fujise K; Liu M
    Cancer Res; 2009 Jan; 69(2):518-25. PubMed ID: 19147565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the tumor vasculature with engineered cystine-knot miniproteins.
    Lui BG; Salomon N; Wüstehube-Lausch J; Daneschdar M; Schmoldt HU; Türeci Ö; Sahin U
    Nat Commun; 2020 Jan; 11(1):295. PubMed ID: 31941901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.